Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway
Conclusion
In conclusion, the present study demonstrated that autophagy was involved in relieving the effects of TSF against NAFLD, which were mediated by the AMPK/SIRT1 pathway (Figure 7D). These findings may improve our current understanding of the role of TSF in treating hepatic steatosis and provide an experimental basis for the clinical application of TSF in NAFLD and its related metabolic syndrome.
Ethics Statement
This study was carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Ethics Committee of the China–Japan Friendship Hospital.
Author Contributions
LP and PL designed the experiments. YW, ZS, QW, and YL performed the experiments. XL, TZ, NL, and NZ analyzed and interpreted the data. HZ and QL drafted the manuscript.
Funding
This work was supported by National Natural Science Foundation of China (81620108031 and 81670758), Beijing Municipal Natural Science Foundation of China (7182147), Capital’s Funds for Health Improvement and Research (2018-2-4062), and Fundamental Research Funds of the Chinese Academy of Medical Sciences (2018RC310023).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary Material
The Supplementary Material for this article can be f...
Source: Frontiers in Physiology - Category: Physiology Source Type: research
More News: Academia | Academies | Adenoviruses | Alcoholism | Anesthesia | Anesthesiology | Antidoxidants | Astragalus | Biochemistry | Biology | Biomedical Science | Biotechnology | Bird Flu | Bitter Orange | Cardiology | Chemistry | China Health | Cholesterol | Complementary Medicine | Coronary Heart Disease | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Diets | Eating Disorders & Weight Management | Education | Endocrinology | Fatty Liver Disease (FLD) | Fluoride | Fortamet | France Health | Fruit | Gastroenterology | Genetics | Germany Health | Heart | Heart Disease | Hepatocellular Carcinoma | Herbs | High Fat | Insulin | Japan Health | Laboratory Medicine | Liver | Liver Cancer | Liver Disease | Medical Ethics | Men | Metabolic Syndrome | Metformin | Mitochondria | Mitochondrial Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Pancreas | Pathology | Perfusion | PET Scan | Phosphorus | Physiology | Proteinuria | Proton Pump Inhibitors PPIs | Reproduction Medicine | Rhubarb | Science | Sodium | Statistics | Study | Taiwan Health | UK Health | Universities & Medical Training | University of Minnesota | Urology & Nephrology | USA Health | Vytorin | Weight Loss | Zetia